SE457255B - 3-aminoproxifenylderivat, deras framstaellning och laekemedel innehaallande dessa - Google Patents

3-aminoproxifenylderivat, deras framstaellning och laekemedel innehaallande dessa

Info

Publication number
SE457255B
SE457255B SE8104236A SE8104236A SE457255B SE 457255 B SE457255 B SE 457255B SE 8104236 A SE8104236 A SE 8104236A SE 8104236 A SE8104236 A SE 8104236A SE 457255 B SE457255 B SE 457255B
Authority
SE
Sweden
Prior art keywords
carbon atoms
alkyl
oxygen
phenyl
group
Prior art date
Application number
SE8104236A
Other languages
English (en)
Swedish (sv)
Inventor
W J Louis
R Berthold
A Stoll
Original Assignee
Louis William John
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Louis William John filed Critical Louis William John
Publication of SE457255B publication Critical patent/SE457255B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8104236A 1980-07-09 1981-07-07 3-aminoproxifenylderivat, deras framstaellning och laekemedel innehaallande dessa SE457255B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8022412 1980-07-09
CH599980 1980-08-07
CH824580 1980-11-06
CH824780 1980-11-06
GB8041155 1980-12-23
GB8104585 1981-02-13

Publications (1)

Publication Number Publication Date
SE457255B true SE457255B (sv) 1988-12-12

Family

ID=27543773

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8104236A SE457255B (sv) 1980-07-09 1981-07-07 3-aminoproxifenylderivat, deras framstaellning och laekemedel innehaallande dessa
SE8104236D SE8104236L (sv) 1980-07-09 1981-07-07 3-aminoproxifenylderivat, deras framstellning och lekemedel innehallande dessa

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8104236D SE8104236L (sv) 1980-07-09 1981-07-07 3-aminoproxifenylderivat, deras framstellning och lekemedel innehallande dessa

Country Status (11)

Country Link
US (2) US4816604A (OSRAM)
AU (1) AU547666B2 (OSRAM)
DE (1) DE3125870C2 (OSRAM)
FR (1) FR2489316B1 (OSRAM)
GB (1) GB2132611B (OSRAM)
IL (1) IL63245A (OSRAM)
IT (1) IT1171374B (OSRAM)
NZ (1) NZ197632A (OSRAM)
PH (1) PH22546A (OSRAM)
SE (2) SE457255B (OSRAM)
WO (1) WO1982000141A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
DE3907512C2 (de) * 1989-03-08 1997-08-14 Laevosan Gmbh & Co Kg Neue Aryloxy-alkylamine, deren Herstellung und diese enthaltende Arzneimittel
US5304367A (en) * 1990-11-16 1994-04-19 New York University In vivo brain imaging agent and method for diagnosis of psychiatric disorders
US5217994A (en) * 1991-08-09 1993-06-08 Merck & Co., Inc. Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives
RU2102069C1 (ru) * 1992-05-22 1998-01-20 Сендзю Фармасьютикал Ко., Лтд. Фармацевтическая композиция для лечения глаукомы
CA2271026C (en) * 1995-10-10 2007-03-13 The University Of Melbourne 3-amino-propoxyphenyl derivatives
WO2012004549A1 (en) 2010-07-05 2012-01-12 The University Of Nottingham Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases
GB201101959D0 (en) * 2011-02-04 2011-03-23 Univ Nottingham Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES373606A1 (es) * 1968-11-18 1972-06-01 Pfizer Un procedimiento para la preparacion de nuevos derivados depropanolamina.
DE2023829C3 (de) * 1970-05-15 1979-06-21 Pfizer Corp., Colon (Panama) Kernsubstituierte 3-Phenoxy-lphenoxyalkyl-amino-propan-2-oIe, Verfahren zu ihrer Herstellung sowie Arzneimittel
AR204105A1 (es) * 1973-01-17 1975-11-20 Ciba Geigy Ag Procedimiento para la preparacion del 1-(4-(2-metiltioetoxi-fenoxi)-2-hidroxi-3-isipropilaminopropano
ZA741812B (en) * 1973-04-18 1975-04-30 Haessle A New amines and process for their preparation
ZA754241B (en) * 1974-11-01 1976-06-30 Haessle Ab New amines
DE2549745A1 (de) * 1974-11-20 1976-05-26 Lipha Durch einen chromonylrest substituierte propionsaeuren sowie deren derivate und verwendungen
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
DE2606140A1 (de) * 1976-02-17 1977-08-25 Boehringer Sohn Ingelheim Neue derivate des 2-phenyl-2-hydroxyaethylamins
DE2614875C2 (de) * 1976-04-06 1978-06-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Alkyl- bzw. Arylthiomethylphenolen
DE2645710C2 (de) * 1976-10-09 1985-06-27 Merck Patent Gmbh, 6100 Darmstadt Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung
FR2368951A2 (fr) * 1976-10-27 1978-05-26 Synthelabo Nouveaux ethers de phenol
JPS6022701B2 (ja) * 1977-06-02 1985-06-03 ウェルファイド株式会社 フエノキシアミノプロパノ−ル誘導体およびその製法
SE7807408L (sv) * 1978-06-30 1979-12-31 Haessle Ab Hjertaktiva foreningar
US4294966A (en) * 1978-07-28 1981-10-13 Ciba-Geigy Corporation Process for inverting the configuration in optically active compounds
DE2838273A1 (de) * 1978-09-01 1980-03-13 Bayer Ag Verfahren zur herstellung von alkyl- bzw. arylthiomethylphenolen
ZW9881A1 (en) * 1980-06-02 1981-12-23 Hoffmann La Roche Substituted phenoxyaminopropanol derivatives

Also Published As

Publication number Publication date
IT8148859A1 (it) 1983-01-08
FR2489316A1 (OSRAM) 1982-03-05
PH22546A (en) 1988-10-17
AU547666B2 (en) 1985-10-31
IT8148859A0 (it) 1981-07-08
US4816604A (en) 1989-03-28
GB2132611B (en) 1985-01-16
AU7263081A (en) 1982-01-14
IT1171374B (it) 1987-06-10
IL63245A (en) 1985-06-30
FR2489316B1 (OSRAM) 1985-01-18
US4970238A (en) 1990-11-13
GB2132611A (en) 1984-07-11
WO1982000141A1 (en) 1982-01-21
GB8324990D0 (en) 1983-10-19
DE3125870C2 (de) 1994-09-15
DE3125870A1 (de) 1982-03-25
IL63245A0 (en) 1981-10-30
SE8104236L (sv) 1982-01-10
NZ197632A (en) 1984-07-31

Similar Documents

Publication Publication Date Title
US4373106A (en) Sulfamoyl-substituted phenethylamine derivatives and process of producing them
RU2067976C1 (ru) Производные арилов или их фармацевтически приемлемые соли и способы их получения
JPH0123462B2 (OSRAM)
WO1992000011A2 (en) Leukotriene b4 antagonists
US4394382A (en) Dihydrobenzopyran compounds and pharmaceutical composition comprising said compounds
NO128653B (OSRAM)
US4062870A (en) Chroman derivatives
EP0052072B1 (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
US3692818A (en) New pharmacologically active esters of n-(3-trifluoromethylphenyl)-anthranilic acid
US4336268A (en) Cyclohexene derivative analgesics
DE3125870C2 (de) 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
EP0034116A2 (en) N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
EP0221958A1 (en) 3-AMINOPROPYLOXYPHENYL DERIVATIVES, PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
US4145443A (en) Bicyclo 3.1.0!hexylethylaminocarbonyl-substituted naphthyloxy cardiovascular agents
US4271193A (en) N1-Benzoyl-N2-phenyldiaminopropanols and pharmaceutical compositions thereof, and processes for their preparation
GB2079750A (en) 3-Aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IE52166B1 (en) 3-aminopropoxyphenyl derivatives,their preparation and pharmaceutical compositions containing them
KR910004719B1 (ko) 벤조페논의 제조방법
US4020071A (en) Derivatives of 1-phenoxy-3-amino-propan-2-ol
EP0096008B1 (en) (+)-cyanidan-3-ol derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter
CH664559A5 (en) 1-amino-3-phenoxy-2-propanol derivs. - useful as alpha and beta blockers
US6933396B2 (en) Process to prepare psorospermin
KR880001563B1 (ko) 3-아미노프로폭시페닐 유도체의 제조방법
JPS625982A (ja) チアゾリジン誘導体
FR2497194A1 (fr) Nouveaux composes phenoliques

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8104236-8

NUG Patent has lapsed

Ref document number: 8104236-8